Internal Medicine, Cardiovascular Disease · Slidell, LA
NPI
1851333587
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
901 Gause Blvd, 2nd Floor
Slidell, LA, 70458
Phone (985) 649-2700
Groups this clinician bills Medicare through
Medicare paid, 2024
$338K
7,108 services
Medicare patients, 2024
658
Average age 75
Drug cost, 2024
$3.1M
18,649 prescriptions
Company payments, 2025
$1,973
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marc Bernstein was code 99214 (office e&m - established), 1,545 times for 594 patients. In total Marc Bernstein billed 7,108 services in 86 codes, and Medicare paid $338K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,545 | 594 | $79.45 | $123K |
| 93000 Electrocardiogram | Office | 1,464 | 596 | $8.73 | $13K |
| 99457 E&M - Miscellaneous | Office | 590 | 112 | $32.95 | $19K |
| 99458 E&M - Miscellaneous | Office | 518 | 98 | $26.93 | $14K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 408 | 102 | $5.18 | $2,113 |
| 99454 E&M - Miscellaneous | Office | 364 | 81 | $30.21 | $11K |
| 93306 Echocardiography (TTE/TEE) | Office | 317 | 308 | $118.44 | $38K |
| 93296 External Electrocardiographic Monitoring | Office | 140 | 54 | $12.77 | $1,787 |
| 93015 Electrocardiogram | Office | 124 | 124 | $42.58 | $5,280 |
| 78452 Myocardial Perfusion Scan | Office | 123 | 123 | $271.60 | $33K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 123 | 122 | $68.52 | $8,427 |
| 85610 Clinical Chemistry | Office | 112 | 13 | $4.16 | $466 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 107 | 105 | $120.32 | $13K |
| 93294 External Electrocardiographic Monitoring | Office | 104 | 42 | $18.82 | $1,957 |
| 93297 External Electrocardiographic Monitoring | Office | 56 | 19 | $34.78 | $1,948 |
By year: 2022 $395K for 10,091 services; 2023 $429K for 14,836 services; 2024 $338K for 7,108 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 112 | 13 | $4.16 | $466 |
Medicare prescription drug claims, 2024
In 2024, the drug Marc Bernstein prescribed most often to Medicare patients was Metoprolol Succinate, with 1,256 prescriptions and refills. In total Marc Bernstein wrote 18,649 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,256 | 3,155 | 360 | $16K |
| Atorvastatin Calcium Generic | 1,232 | 3,299 | 343 | $12K |
| Rosuvastatin Calcium Generic | 851 | 2,283 | 252 | $11K |
| Amlodipine Besylate Generic | 824 | 2,061 | 243 | $3,173 |
| Eliquis Apixaban | 773 | 1,293 | 160 | $731K |
| Clopidogrel Clopidogrel Bisulfate | 722 | 1,741 | 179 | $5,561 |
| Lisinopril Generic | 711 | 1,731 | 185 | $3,612 |
| Carvedilol Generic | 688 | 1,754 | 180 | $5,215 |
| Losartan Potassium Generic | 656 | 1,712 | 187 | $5,581 |
| Ezetimibe Generic | 563 | 1,448 | 172 | $11K |
| Furosemide Generic | 455 | 1,057 | 148 | $1,397 |
| Pantoprazole Sodium Generic | 391 | 934 | 103 | $3,567 |
| Entresto Sacubitril/Valsartan | 350 | 540 | 70 | $340K |
| Levothyroxine Sodium Generic | 332 | 906 | 92 | $2,620 |
| Hydrochlorothiazide Generic | 330 | 870 | 102 | $1,234 |
Brand drugs: 3,385 claims; generic drugs: 15,248 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marc Bernstein $1,973 ($1,973 in general payments such as food, travel and fees) from 21 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $438.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 24 | $438 |
| Novartis Pharmaceuticals Corporation NVS | 26 | $281 |
| Pfizer Inc. PFE | 12 | $214 |
| Merck Sharp & Dohme LLC MRK | 11 | $203 |
| Novo Nordisk Inc NVO | 6 | $134 |
| Abbott Laboratories ABT | 2 | $113 |
| Amgen Inc. AMGN | 5 | $90.24 |
| Scpharmaceuticals Inc. SCPH | 4 | $72.88 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $69.76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $69.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.